The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
CTLA-4 ligation blocks CD28-dependent T cell activation.
Open accessAbstract
CTLA-4 is a CD28 homologue believed to be a negative regulator of T cell function. However, the mechanism of this downregulatory activity is not well understood. The present study was designed to examine the effect of CTLA-4 ligation on cytokine production, cell survival, and cell cycle progression. The results demonstrate that the primary effect of CTLA-4 ligation is not the induction of apoptosis. Instead, CTLA-4 signaling blocks IL-2 production, IL-2 receptor expression, and cell cycle progression of activated T cells. Moreover, the effect of CTLA-4 signaling was manifested after initial T cell activation. Inhibition of IL-2 receptor expression and cell cycle progression was more pronounced at late (72 h) time points after initial activation. The effects of anti-CTLA-4 mAbs were most apparent in the presence of optimal CD28-mediated costimulation consistent with the finding that CTLA-4 upregulation was CD28-dependent. Finally, the addition of exogenous IL-2 to the cultures restored IL-2 receptor expression and T cell proliferation. These results suggest that CTLA-4 signaling does not regulate cell survival or responsiveness to IL-2, but does inhibit CD28-dependent IL-2 production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Self-citationLymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel, M. F., & Allison, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.459 · Cited by 2,245
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Self-citationCTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685
Identification of a monoclonal antibody specific for a murine T3 polypeptide.
Leo, O., Foo, M., Sachs, D. H., Samelson, L. E., & Bluestone, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1374 · Cited by 1,593
Self-citationA new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Unkeless, J. C. (1979) · The Journal of experimental medicine · doi:10.1084/jem.150.3.580 · Cited by 1,237
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210
Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Induction of apoptosis in mature T cells by tumour necrosis factor
Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H., & Lenardo, M. J. (1995) · Nature · doi:10.1038/377348a0 · Cited by 1,116
Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A., & Peach, R. (1994) · Immunity · doi:10.1016/s1074-7613(94)80021-9 · Cited by 980
Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation Pathway
Lindstein, T., June, C. H., Ledbetter, J. A., Stella, G., & Thompson, C. B. (1989) · Science · doi:10.1126/science.2540528 · Cited by 878
Sarmiento, M., Glasebrook, A. L., & Fitch, F. W. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.6.2665 · Cited by 802
Positive and negative selection of an antigen receptor on T cells in transgenic mice
Sha, W. C., Nelson, C. A., Newberry, R. D., Kranz, D. M., Russell, J. H., & Loh, D. Y. (1988) · Nature · doi:10.1038/336073a0 · Cited by 743
Singer, G. G., & Abbas, A. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90067-1 · Cited by 691
Regulation of Interleukin-2 Gene Enhancer Activity by the T Cell Accessory Molecule CD28
Fraser, J. D., Irving, B. A., Crabtree, G. R., & Weiss, A. (1991) · Science · doi:10.1126/science.1846244 · Cited by 641
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley, P. S., Greene, J. L., Tan, P., Bradshaw, J., Ledbetter, J. A., Anasetti, C., & Damle, N. K. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1595 · Cited by 581
Ozato, K., & Sachs, D. H. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.1.317 · Cited by 571
A monoclonal antibody discriminating between subsets of T and B cells.
Bruce, J., Symington, F. W., McKearn, T. J., & Sprent, J. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.6.2496 · Cited by 542
Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation
Hathcock, K. S., Laszlo, G., Dickler, H. B., Bradshaw, J., Linsley, P., & Hodes, R. J. (1993) · Science · doi:10.1126/science.7694361 · Cited by 517
Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C., & Nadler, L. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6575 · Cited by 427
CTLA4 mediates antigen-specific apoptosis of human T cells.
Gribben, J. G., Freeman, G. J., Boussiotis, V. A., Rennert, P., Jellis, C. L., Greenfield, E., Barber, M., Restivo, V. A., Ke, X., & Gray, G. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.811 · Cited by 317
Characterization of CTLA-4 structure and expression on human T cells.
Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B., Freeman, G. J., Nadler, L. M., Gray, G. S., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3489 · Cited by 316
Kearney, E. R., Walunas, T. L., Karr, R. W., Morton, P. A., Loh, D. Y., Bluestone, J. A., & Jenkins, M. K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1032 · Cited by 312
Self-citationIdentification and distribution of the costimulatory receptor CD28 in the mouse
Gross, J. A., Callas, E., & Allison, J. P. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.380 · Cited by 309
Expression and functional significance of an additional ligand for CTLA-4.
Lenschow, D. J., Su, G. H., Zuckerman, L. A., Nabavi, N., Jellis, C. L., Gray, G. S., Miller, J., & Bluestone, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11054 · Cited by 259
Self-citationLucas, P. J., Negishi, I., Nakayama, K., Fields, L. E., & Loh, D. Y. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.5757 · Cited by 218
Razi-Wolf, Z., Freeman, G. J., Galvin, F., Benacerraf, B., Nadler, L., & Reiser, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4210 · Cited by 210
Seder, R. A., Germain, R. N., Linsley, P. S., & Paul, W. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.299 · Cited by 205
Verweij, C. L., Geerts, M., & Aarden, L. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98663-1 · Cited by 186
Kranz, D. M., Tonegawa, S., & Eisen, H. N. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7922 · Cited by 174
CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells.
Schneider, H., Prasad, K. V., Shoelson, S. E., & Rudd, C. E. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.351 · Cited by 165
INHIBITION OF TRANSPLANT REJECTION FOLLOWING TREATMENT WITH ANTI-B7-2 AND ANTI-B7-1 ANTIBODIES
Lenschow, D. J., Zeng, Y., Hathcock, K. S., Zuckerman, L. A., Freeman, G., Thistlethwaite, J. R., Gray, G. S., Hodes, R. J., & Bluestone, J. A. (1995) · Transplantation · doi:10.1097/00007890-199511270-00019 · Cited by 160
Self-citationApoptosis, fas and systemic autoimmunity: the MRL-Ipr/Ipr model
Singer, G. G., Carrera, A. C., Marshak‐Rothstein, A., Martínez‐A, C., & Abbas, A. K. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90013-2 · Cited by 152
Wu, J., Zhou, T., Zhang, J., He, J., Gause, W. C., & Mountz, J. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2344 · Cited by 140
Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
Abe, R., Vandenberghe, P., Craighead, N., Smoot, D. S., Lee, K. P., & June, C. H. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.985 · Cited by 120
CD28 activation promotes Th2 subset differentiation by human CD4+ cells
King, C. L., Stupi, R. J., Craighead, N., June, C. H., & Thyphronitis, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250242 · Cited by 119
Damle, N. K., Klussman, K., Leytze, G., Myrdal, S. E., Aruffo, A. A., Ledbetter, J. A., & Linsley, P. S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.2686 · Cited by 87
Activated T cells can induce high levels of CTLA-4 expression on B cells
Kuiper, H. M., Brouwer, M. C., Linsley, P. S., & van Lier, R. A. W. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.1776 · Cited by 81
Cited by
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Read, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712
Metadata
- Authors
- Walunas, T. L., Bakker, C. Y., & Bluestone, J. A.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-06-01
- Volume
- 183
- Issue
- 6
- Pages
- 2541-2550
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2164903177
- Cited by
- 801
- References
- 41
- FWCI
- 17.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.